-
Asthma and COPD Drugs Market to Grow at a CAGR of 7.9% and will Reach USD 73.98 billion by 2032
19 Mar 2025 17:24 GMT
… COPD Drugs Market Companies
Teva Pharmaceutical Industries Ltd … Dulera
Others
Anticholinergics
Spiriva
Others
Inhaled … the doctors have prescribed the drug.
Read … and personalized medicine are improving treatment efficacy and …
-
Ozempic, Biktarvy Among the Drugs Seeing List Price Increases at the Start of 2025
21 Jan 2025 19:02 GMT
… and Janumet XR), tiotropium bromine (Spiriva; Boehringer Ingelheim), ipratropium bromine (Atrovent … . HHS Announces Next 15 Drugs for Medicare Part D Price Negotiations. Pharmacy … /hhs-announces-next-15-drugs-for-medicare-part-d-price-negotiations
-
Chronic Obstructive Pulmonary Disease Treatment Market 2034: Clinical Trials, FDA Approvals, Companies by DelveInsight
18 Dec 2024 16:28 GMT
… Pharmaceuticals, and several others.
• Chronic Obstructive Pulmonary Disease drugs: Stiolto Respimat (Boehringer Ingelheim), Spiriva Respimat and Spiriva … Trials and FDA Approvals
Chronic … COPD) Treatment Algorithm, Current Treatment, and Medical Practices
9 …
-
Sanofi/Regeneron Pharmaceuticals' DUPIXENT Approval Marks A Significant Shift In Chronic Obstructive Pulmonary Disease Treatment Landscape Delveinsight
12 Nov 2024 23:46 GMT
… about the FDA-approved COPD drugs @ Drugs for COPD Treatment
Recently, Sanofi/Regeneron Pharmaceuticals'; DUPIXENT …
-
Spiriva and cost
07 Oct 2024 12:58 GMT
… and your doctor will discuss Spiriva in regard to your treatment. The insurance … your doctor or another healthcare professional before taking any medication. The drug information …
-
27 Individuals Indicted for Buying and Selling Wholesale Quantities of Misbranded and Diverted Prescription Drugs Resold to the Public Through Retail Pharmacies in Puerto Rico
27 Sep 2024 16:15 GMT
… licensed pharmaceutical distribution channels. By selling diverted prescription drugs and … , Segluromet, Selegline, Silver, Soliqua, Spiriva, Steglatro, Stiolto Respimat, Stribild, Symbicort … on the FDA website. If someone is having a medical emergency, …
-
USFDA scrutiny delays generic drug approvals for major Indian pharma firms
30 Jul 2024 05:41 GMT
… of new drugs from major Indian pharmaceutical companies in … in research organisations for drug manufacturing.
US pharma … (a cancer drug) and Spiriva (a respiratory drug), are expected … hurdles, major Indian pharmaceutical companies are expected to …
-
Asthma Inhaler Costs to Be Slashed as Drugmakers Introduce $35 Price Cap
02 Jun 2024 12:10 GMT
… Cut to $35
Three major pharmaceutical companies-AstraZeneca, Boehringer Ingelheim, and … step towards making these essential medications more affordable for patients.
… bromide and albuterol) inhalation spray
Spiriva HandiHaler (tiotropium bromide inhalation …
-
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
06 May 2024 23:10 GMT
… strong demand for its drugs in North America and … generic drugmakers Dr. Reddy’s Laboratories, Cipla and Sun Pharmaceutical … versions of the blockbuster cancer drug, Revlimid.
Show Full … copycat version of asthma drug Spiriva Handihaler, which was launched …
-
Drug Wars Continue Despite Registry Patent Listing Crackdown
25 Mar 2024 05:41 GMT
… federal registry of approved drugs than Teva Pharmaceutical Industries Ltd., the … FDA’s Orange Book goes on to help the generic-drug … 12 patents for asthma treatment. Seven of the patents … Boehringer’s top selling Spiriva HandiHaler. Alvogen in October …
About
© 1995-2025